What is labelling efficiency in nuclear medicine?
Labelling efficiency refers to the proportion of a radionuclide that successfully binds to the intended pharmaceutical compound during preparation of a radiopharmaceutical.
It is usually expressed as a percentage of total radioactivity that is present in the desired labelled form. High labelling efficiency ensures correct biodistribution and optimal image quality, while poor labelling efficiency can result in free radionuclide or unwanted chemical species.
Labelling efficiency is the percentage of radionuclide successfully bound to the intended compound, directly influencing image quality and biodistribution.
Labelling efficiency is closely related to radiochemical purity.
Understanding the physics
When a radionuclide is combined with a carrier molecule, a chemical reaction occurs to form the final radiopharmaceutical. However, this reaction may not be 100% efficient.
For example, when Tc-99m pertechnetate is added to a kit containing a ligand and a reducing agent, the technetium must:
Be reduced from its high oxidation state.
Bind correctly to the ligand.
If this process is incomplete, some technetium may remain as:
Free pertechnetate
Hydrolysed-reduced technetium
Incorrectly bound species
Labelling efficiency measures how much of the total activity is present in the correctly labelled compound.
Factors influencing labelling efficiency include:
pH of the reaction mixture
Temperature
Presence of oxygen
Age of the generator eluate
Aluminium contamination
Correct reagent preparation
Low labelling efficiency leads to reduced radiochemical purity and altered biodistribution.
For example, free pertechnetate may accumulate in the thyroid and stomach rather than in the intended target organ.
Where this matters clinically
Poor labelling efficiency can result in non-diagnostic images or unexpected tracer distribution. Routine quality control testing ensures that the majority of administered activity is in the correct labelled form.
Understanding labelling efficiency is essential for interpreting abnormal biodistribution patterns and for safe radiopharmaceutical preparation.